RCA
FLGT icon

Ranch Capital Advisors’s Fulgent Genetics FLGT Stock Holding History

Ranch Capital Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-130
Closed -$6K – 874
2020
Q4 		$6K Hold
130
– – ﹤0.01% 703
2020
Q3 		$5K Sell
130
-1,000
-88% -$31.3K ﹤0.01% 717
2020
Q2 		$49K Hold
1,130
– – 0.04% 307
2020
Q1 		$12K Hold
1,130
– – 0.01% 550
2019
Q4 		$15K Buy
+1,130
New +$13.4K 0.01% 572

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ranch Capital Advisors's FLGT Position: Q1 2021 in Review

Ranch Capital Advisors sold out of Fulgent Genetics (FLGT) in Q1 2021, closing a stake of 130 shares — an estimated $6K sold.

Ranch Capital Advisors first reported a position in FLGT in Q4 2019 and held it in 5 quarters. The position peaked at $49K in Q2 2020. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

  • Ranch Capital Advisors reported no remaining Fulgent Genetics position as of Q1 2021 after selling out during the quarter.
  • Ranch Capital Advisors sold 130 Fulgent Genetics shares in Q1 2021, an estimated $6K.
  • Ranch Capital Advisors first reported a position in Fulgent Genetics in Q4 2019 and held it in 5 quarters.
  • Ranch Capital Advisors's Fulgent Genetics position peaked at $49K in Q2 2020.
  • 256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Ranch Capital Advisors's 13F filing for Q1 2021, filed 17 May 2021.